Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The histamine H4 receptor (HRH4) modulates eosinophil migration and selective recruitment of mast cells leading to amplification of histamine-mediated immune responses and eventually to chronic inflammation. H4 receptor involvement in dendritic cell activation and T cell differentiation documents its immunomodulatory function.
The HRH4 pipeline market research report provides comprehensive information on the HRH4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, the latest news as well as press releases. Additionally, the report provides an overview of key players involved in Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) targeted therapeutics development with respective active and dormant or discontinued projects.
Key Therapy Areas in the HRH4 Pipeline Products Market
The key therapy areas in the HRH4 pipeline products market are dermatology, ear nose throat disorders, immunology, ophthalmology, and respiratory.
HRH4 Pipeline Products Market Analysis by Therapy Areas
For more therapy area insights, download a free report sample
Key Mechanisms of Action in the HRH4 Pipeline Products Market
The key mechanisms of action in the HRH4 pipeline products market are Histamine H4 Receptor Antagonist and Histamine H4 Receptor Agonist.
HRH4 Pipeline Products Market Analysis by Mechanisms of Action
For more mechanisms of action insights, download a free report sample
Key Routes of Administration in the HRH4 Pipeline Products Market
The key routes of administration in the HRH4 pipeline products market are oral and parenteral.
HRH4 Pipeline Products Market Analysis by Routes of Administration
For more routes of administration insights, download a free report sample
Key Molecule Types in the HRH4 Pipeline Products Market
The key molecule type in the HRH4 pipeline products market is small molecule.
Major Companies in the HRH4 Pipeline Products Market
The major companies in the HRH4 pipeline products market are Bioprojet SCR, H4Orphan Pharma, JW Pharmaceutical Corp, Leo Pharma AS, Sensorion SA, and Sosei Group Corp.
HRH4 Pipeline Products Market Analysis by Companies
To know more about major companies, download a free report sample
HRH4 Pipeline Products Market Report Overview
Key Therapy Areas | Dermatology, Ear Nose Throat Disorders, Immunology, Ophthalmology, and Respiratory |
Key Mechanisms of Action | Histamine H4 Receptor Antagonist and Histamine H4 Receptor Agonist |
Key Routes of Administration | Oral and Parenteral |
Key Molecule Type | Small Molecule |
Major Companies | Bioprojet SCR, H4Orphan Pharma, JW Pharmaceutical Corp, Leo Pharma AS, Sensorion SA, and Sosei Group Corp |
Scope
- The report provides a snapshot of the global therapeutic landscape for Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4)
- The report reviews Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing, and collaboration details & other developmental activities
- The report reviews key players involved in Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) targeted therapeutics and enlists all their major and minor projects
- The report assesses Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews the latest news and deals related to Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) targeted therapeutics
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage
- Identify and understand the targeted therapy areas and indications for Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and their most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key therapy areas in the HRH4 pipeline products market?
The key therapy areas in the HRH4 pipeline products market are dermatology, ear nose throat disorders, immunology, ophthalmology, and respiratory.
-
What are the key mechanisms of action in the HRH4 pipeline products market?
The key mechanisms of action in the HRH4 pipeline products market are Histamine H4 Receptor Antagonist and Histamine H4 Receptor Agonist.
-
What are the key routes of administration in the HRH4 pipeline products market?
The key routes of administration in the HRH4 pipeline products market are oral and parenteral.
-
What are the key molecule types in the HRH4 pipeline products market?
The key molecule type in the HRH4 pipeline products market is small molecule.
-
Which are the major companies in the HRH4 pipeline products market?
The major companies in the HRH4 pipeline products market are Bioprojet SCR, H4Orphan Pharma, JW Pharmaceutical Corp, Leo Pharma AS, Sensorion SA, and Sosei Group Corp.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.